8-K//Current report
Bausch & Lomb Corp 8-K
Accession 0000950103-26-000051
$BLCOCIK 0001860742operating
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:10 PM ET
Size
2.7 MB
Accession
0000950103-26-000051
Research Summary
AI-generated summary of this filing
Bausch & Lomb Corp Announces $2.802B Term Loan Refinancing
What Happened
- Bausch & Lomb Corporation announced on January 2, 2026 that it entered into a Fourth Amendment to its Credit and Guaranty Agreement and obtained a new $2,802,125,000 tranche of term loans (the "Replacement Term Loans"). The new loans were used to refinance the Company’s outstanding term B loans due 2031 and term B loans due 2028.
- The Replacement Term Loans mature on January 15, 2031 and are governed under the existing credit facility administered by JPMorgan Chase Bank, N.A. A press release announcing the closing was issued the same day.
Key Details
- Principal amount: $2,802,125,000 in Replacement Term Loans (effective January 2, 2026).
- Maturity: January 15, 2031 (this preserves the 2031 maturity for prior 2031 loans and extends the 2028 loans to 2031).
- Interest and margins: applicable margin is 3.75% per annum for loans priced to term SOFR and 2.75% per annum for loans priced to the alternate base rate.
- Amortization: 1.00% per annum with the first installment due June 30, 2026.
- Margin reductions versus replaced tranches: 0.50% lower than the Third Amendment Term Loans and 0.25% lower than the First Incremental Term Loans.
Why It Matters
- This transaction creates a new direct financial obligation and changes the company’s debt profile by extending maturities for certain borrowings to 2031, which reduces near-term refinancing risk for those loans.
- The reduced margins could lower Bausch & Lomb’s interest costs on the refinanced debt compared with the prior tranches, while the 1% amortization schedule begins mid-2026 and will affect future cash outflows.
- Investors should consider the impact on the company’s leverage, interest expense and cash flow timing; the filing and attached press release provide the formal terms for review.
Documents
- 8-Kdp239510_8k.htmPrimary
FORM 8-K
- EX-10.1dp239510_ex1001.htm
EXHIBIT 10.1
- EX-99.1dp239510_ex9901.htm
EXHIBIT 99.1
- GRAPHICimage_001.jpg
GRAPHIC
- EX-101.SCHblco-20260102.xsd
XBRL SCHEMA FILE
- EX-101.LABblco-20260102_lab.xml
XBRL LABEL FILE
- EX-101.PREblco-20260102_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950103-26-000051-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLdp239510_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Bausch & Lomb Corp
CIK 0001860742
Entity typeoperating
Related Parties
1- filerCIK 0001860742
Filing Metadata
- Form type
- 8-K
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:10 PM ET
- Size
- 2.7 MB